Completed OBSERVATIONAL NCT01669824

Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg

Tolerability, Compliance and Indications of Aspirin Protect 100 mg in Longterm Use (12 Months) Under Everyday's Conditions - Data Collection With Questionnaires Handed Out in Pharmacies to Aspirin Protect 100 mg Consumers

Sponsor: Bayer

Conditions Aspirin Drug Safety Effects, Longterm

Interventions Acetylsalicylic acid (Aspirin, BAYE4465)

Updated 6 times since 2017 Last updated: Sep 6, 2023 Started: Aug 31, 2007 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Aspirin and Drug Safety and is currently completed. Bayer leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2023 — Jul 2024 [monthly]

Completed
Jan 2021 — Oct 2023 [monthly]

Completed
Apr 2018 — Jan 2021 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer

Data source: Bayer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Multiple Locations, Germany